Summary
The administration of phenylalanine (Phe) combined with UVA exposure was found to be effective in vitiligo. Phe is an amino acid which constitutes part of the daily dietary protein, and when orally administered in a dose of 50 mg/kg body weight, it results in an elevated plasma level. Since peak concentrations of Phe in the blood are reached between 30 and 45 min after ingestion, UVA exposure was administered at this time. After 4 months (32 treatments) reasonable repigmentation preferentially occurred in the skin area of subcutaneous fat (adipose tissue). Apart from the repigmentation of hypopigmented macules, vitiligo patients can tolerate more sun than usual, especially at the vitiliginous lesion, and they experience no sunburn as a result of Phe-UVA therapy. Normal skin also tans very well.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blau K, Summer GK, Newsome HC, Edwards CH, Mamer OA (1973) Phenylalanine loading and aromatic acid excretion in normal subjects and heterozygotes for phenylketonuria. Clin Chim Acta 45:197–205
Cunliffe WJ, Hall R, Newell DJ, Stevenson CJ (1968) Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 80:135–139
Dolecek R (1968) Treatment of vitiligo. Br Med J 4:327
El Mofty AM (1968) Vitiligo and psoralens. Pergamon, London
Farah FS, Kurban AK, Chaglassian HT (1967) The treatment of vitiligo with psoralens and triamcinolone by mouth. Br J Dermatol 79:89–91
Fitzpatrick TB, arndt KA, El Mofty AM, Pathak MA (1966) Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Arch Dermatol 93:589–600
Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (1979) Dermatology in general medicine. McGraw-Hill Publications, NY, pp 568–629
Hassel CW, Brunsting LA (1959) Phenylpyruvic oligophrenia: an evaluaton of light-sensitive and pigmentary characteristics of seventeen patients. Arch Dermatol 79:458–465
Jervis GA (1960) Detection of heterozygotes for phenylketonuria. Clin Chim Acta 5:471–476
Kaidbey KH, Kligman AM (1973) Photopigmentation with Trioxsalen. Arch Dermatol Res 109:647–677
Lerner AB (1959) Vitiligo. J Invest Dermatol 32:285–310
Lerner AB (1971) On the etiology of vitiligo and gray hair. Am J Med 51:141–147
Moore S, Spackman DH, Stein WH (1958) Chromatography of amino acids on sulphonated polystyrene resins. An improved system. Anal Chem 30:1185–1190
Perry TL, Hansens S, Diamond S, Stedman D (1969) Plasma amino acid levels in Huntington's chorea. Lancet 1:806–808
Sehgal VN (1971) Oral trimethylpsoralen in vitiligo in children. A preliminary report. Br J Dermatol 85:454–456
Snyderman SE, Norton P, Holt LE Jr (1955) Effect of tyrosine administration in phenylketonuria. Fed Proc 14:450–451
Soupart P (1959) Urinary excretion of free amino acids in normal adult men and women. Clin Chim Acta 4:265–271
Spackman DH, Stein WH, Moore S (1958) Automatic recording apparatus for use in the chromatography of amino acids. Anal Chem 30:1190–1206
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cormane, R.H., Siddiqui, A.H., Westerhof, W. et al. Phenylalanine and UVA light for the treatment of vitiligo. Arch Dermatol Res 277, 126–130 (1985). https://doi.org/10.1007/BF00414110
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00414110